Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Brand

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 5, 2013
Long-term application of the aldosterone antagonist spironolactone prevents stiff endothelial cell syndromeVerena Drüppel, Kristina Kusche-Vihrog, Claudia Grossmann, et al.
BMJ Open|November 24, 2012
Effects of enzyme replacement therapy in adult patients with Fabry disease on cardiac structure and function: a retrospective cohort study of the Fabry Munster Study (FaMuS) dataMarkus A Engelen, Eva Brand, Timo B Baumeister, et al.
Hypertension (Dallas, Tex. : 1979)|January 15, 2014
Soluble adenylyl cyclase in vascular endothelium: gene expression control of epithelial sodium channel-α, Na+/K+-ATPase-α/β, and mineralocorticoid receptorBoris Schmitz, Johanna Nedele, Katrin Guske, et al.
Molecular Genetics and Metabolism|January 29, 2023
Patient reported quality of life and medication adherence in Fabry disease patients treated with migalastat: A prospective, multicenter studyJonas Müntze, Kolja Lau, Markus Cybulla, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 21, 2003
Uncoupling protein 1 and 3 polymorphisms are associated with waist-to-hip ratioStefan-Martin Herrmann, Ji-Guang Wang, Jan A Staessen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 8, 2009
Identification and functional analyses of molecular haplotypes of the human osteoprotegerin gene promoterClaudia Hagedorn, Ralph Telgmann, Corinna Dördelmann, et al.
American Heart Journal|September 11, 2013
The Coronary Artery Disease and Renal Failure (CAD-REF) registry: trial design, methods, and aimsEva Brand, Hermann Pavenstädt, Roland E Schmieder, et al.
Human Molecular Genetics|February 5, 2003
Differential binding of transcription factor E2F-2 to the endothelin-converting enzyme-1b promoter affects blood pressure regulationHeiko Funke-Kaiser, Florian Reichenberger, Karla Köpke, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 9, 2013
Interindividual transcriptional regulation of the human biglycan gene involves three common molecular haplotypesBoris Schmitz, Andrea Salomon, Alois Rötrige, et al.
Neurology|February 10, 2015
Thromboembolic events in Fabry disease and the impact of factor V LeidenMalte Lenders, Nesrin Karabul, Thomas Duning, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 5, 2013
Long-term application of the aldosterone antagonist spironolactone prevents stiff endothelial cell syndromeVerena Drüppel, Kristina Kusche-Vihrog, Claudia Grossmann, et al.
BMJ Open|November 24, 2012
Effects of enzyme replacement therapy in adult patients with Fabry disease on cardiac structure and function: a retrospective cohort study of the Fabry Munster Study (FaMuS) dataMarkus A Engelen, Eva Brand, Timo B Baumeister, et al.
Hypertension (Dallas, Tex. : 1979)|January 15, 2014
Soluble adenylyl cyclase in vascular endothelium: gene expression control of epithelial sodium channel-α, Na+/K+-ATPase-α/β, and mineralocorticoid receptorBoris Schmitz, Johanna Nedele, Katrin Guske, et al.
Molecular Genetics and Metabolism|January 29, 2023
Patient reported quality of life and medication adherence in Fabry disease patients treated with migalastat: A prospective, multicenter studyJonas Müntze, Kolja Lau, Markus Cybulla, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 21, 2003
Uncoupling protein 1 and 3 polymorphisms are associated with waist-to-hip ratioStefan-Martin Herrmann, Ji-Guang Wang, Jan A Staessen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 8, 2009
Identification and functional analyses of molecular haplotypes of the human osteoprotegerin gene promoterClaudia Hagedorn, Ralph Telgmann, Corinna Dördelmann, et al.
American Heart Journal|September 11, 2013
The Coronary Artery Disease and Renal Failure (CAD-REF) registry: trial design, methods, and aimsEva Brand, Hermann Pavenstädt, Roland E Schmieder, et al.
Human Molecular Genetics|February 5, 2003
Differential binding of transcription factor E2F-2 to the endothelin-converting enzyme-1b promoter affects blood pressure regulationHeiko Funke-Kaiser, Florian Reichenberger, Karla Köpke, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 9, 2013
Interindividual transcriptional regulation of the human biglycan gene involves three common molecular haplotypesBoris Schmitz, Andrea Salomon, Alois Rötrige, et al.
Neurology|February 10, 2015
Thromboembolic events in Fabry disease and the impact of factor V LeidenMalte Lenders, Nesrin Karabul, Thomas Duning, et al.
Pageof 13